二次注射动脉期成像克服钆塞酸增强肝脏MRI动脉期图像质量下降
研究纳入172例在钆塞酸增强肝脏MRI常规动态成像后追加注射4 mL对比剂行二次注射动脉期(SSAP)成像的患者,SSAP图像运动伪影评分显著低于原始动脉期(1.76 vs 2.06,p<0.001),在原始动脉期有明显运动伪影的患者中改善更明显(2.28 vs 3.28,p<0.001)。30个原始动脉期呈富血供的HCC病灶中仅4个(13.3%)在SSAP图像上呈高信号,但SSAP减影图像清楚显示全部HCC的动脉期富血供。
要点
- SSAP图像运动伪影显著低于原始动脉期(1.76 vs 2.06,p<0.001)。
- 原始动脉期有明显运动伪影者SSAP改善更显著(2.28 vs 3.28,p<0.001)。
- SSAP减影图像可维持HCC动脉期富血供的检出能力。
核心结论
- SSAP图像运动伪影显著少于原始动脉期图像,SSAP减影图像维持了动脉期富血供的检出能力,但SSAP图像对HCC动脉期富血供的视觉检出较差。
研究设计与样本
- 研究纳入172例在钆塞酸增强肝脏MRI常规动态成像后追加注射4 mL对比剂行SSAP成像的患者;采用5分制评分比较原始动脉期与SSAP图像的运动伪影,并评估原始动脉期、SSAP及其减影图像对富血供HCC动脉期富血供的视觉检出率。
关键影像表现/征象
- SSAP图像运动伪影评分显著低于原始动脉期图像(平均评分1.76 vs 2.06,p<0.001)。
- 原始动脉期有明显运动伪影的患者中,SSAP图像运动伪影显著降低(2.28 vs 3.28,p<0.001)。
- 30个原始动脉期呈富血供的HCC病灶中,仅4个(4/30,13.3%)在SSAP图像上呈高信号。
- SSAP减影图像清楚显示全部HCC的动脉期富血供。
诊断标准与关键数值
- 运动伪影采用5分制评分,SSAP与原始动脉期平均评分分别为1.76与2.06(p<0.001)。
- 原始动脉期有明显运动伪影者中,SSAP与原始动脉期评分分别为2.28与3.28(p<0.001)。
- 30个原始动脉期呈富血供的HCC病灶中,SSAP图像视觉检出富血供者4个(13.3%),SSAP减影图像检出全部HCC的动脉期富血供。
临床应用与阅片要点
- SSAP成像可减少动脉期运动伪影,尤其适用于原始动脉期有明显运动伪影的患者。
- 阅片时应结合SSAP减影图像评估HCC动脉期富血供,不宜仅依赖SSAP原始图像。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Second shot arterial phase (SSAP) imaging is an additional arterial phase image obtained by re-injecting a small amount of contrast medium after routine dynamic imaging in gadoxetic acid-enhanced liver MRI. We aimed to evaluate the feasibility and additional value of a SSAP image in gadoxetic acid-enhanced liver MRI.
METHODS: One hundred seventy-two patients who underwent SSAP imaging after re-injection of 4 mL of contrast material after routine dynamic imaging (original) in gadoxetic acid-enhanced liver MRIs were included. Motion artifacts on arterial phase (AP) images were rated using a 5-point scale and were compared between the original AP images and SSAP images. We evaluated visual detection rates of arterial hypervascularity on the original AP and SSAP images and their subtraction images in patients with hypervascular hepatocellular carcinoma (HCC).
RESULTS: The motion artifact of the SSAP images was significantly lower than that of the original AP images (mean score, 1.76 vs 2.06; p < 0.001). In particular, motion artifacts reduced significantly in the SSAP images of patients with substantial motion artifacts in their original AP images (2.28 vs 3.28; p < 0.001). Among the 30 HCC lesions showing hypervascularity on original AP images, only four (4/30, 13.3%) appeared hyperintense on SSAP images. However, subtraction images of SSAP clearly demonstrated arterial hypervascularity in all HCCs.
CONCLUSION: SSAP images showed significantly fewer motion artifacts than the original AP images. Subtraction images of SSAP maintained the detectability of arterial hypervascularity, although SSAP images showed poor visual detection of arterial hypervascularity of HCC.
KEY POINTS: • Arterial phase images obtained after a second injection of a small amount of contrast medium (second shot arterial phase [SSAP]) improved motion artifacts compared to the original AP images. • The motion artifacts improved significantly in the SSAP images of patients with substantial motion artifacts in their original AP images. • Subtraction images of SSAP demonstrated the arterial hypervascularity characteristic of HCC at a level comparable to that of the original AP image.
引用
- Park YS, Lee J, Kim JW, et al. Second shot arterial phase to overcome degraded hepatic arterial phase in liver MR imaging. Eur Radiol. 2018. PMID: 30552478. doi:10.1007/s00330-018-5897-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。